Literature DB >> 9641937

Communicating the risk reduction achieved by cholesterol reducing drugs.

J A Skolbekken1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9641937      PMCID： PMC1113406          DOI： 10.1136/bmj.316.7149.1956

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  20 in total

1.  Absolutely relative: how research results are summarized can affect treatment decisions.

Authors:  L Forrow; W C Taylor; R M Arnold
Journal:  Am J Med       Date:  1992-02       Impact factor: 4.965

2.  Doubts about preventing coronary heart disease.

Authors:  M F Oliver
Journal:  BMJ       Date:  1992-02-15

Review 3.  Chronic infections and coronary heart disease: is there a link?

Authors:  J Danesh; R Collins; R Peto
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

4.  Can we treat coronary artery disease with antibiotics?

Authors:  G Y Lip; D G Beevers
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

5.  The number needed to treat: a clinically useful measure of treatment effect.

Authors:  R J Cook; D L Sackett
Journal:  BMJ       Date:  1995-02-18

6.  [What attitude do physicians have towards risk?].

Authors:  I Hetlevik; J Holmen
Journal:  Tidsskr Nor Laegeforen       Date:  1994-06-10

7.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

8.  The framing effect of relative and absolute risk.

Authors:  D J Malenka; J A Baron; S Johansen; J W Wahrenberger; J M Ross
Journal:  J Gen Intern Med       Date:  1993-10       Impact factor: 5.128

9.  Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration.

Authors:  H C Bucher; M Weinbacher; K Gyr
Journal:  BMJ       Date:  1994-09-24

10.  Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?

Authors:  C D Naylor; E Chen; B Strauss
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391
View more
  22 in total

Review 1.  The effects of information framing on the practices of physicians.

Authors:  P McGettigan; K Sly; D O'Connell; S Hill; D Henry
Journal:  J Gen Intern Med       Date:  1999-10       Impact factor: 5.128

Review 2.  Understanding risk and lessons for clinical risk communication about treatment preferences.

Authors:  A Edwards; G Elwyn
Journal:  Qual Health Care       Date:  2001-09

Review 3.  Explaining risks: turning numerical data into meaningful pictures.

Authors:  Adrian Edwards; Glyn Elwyn; Al Mulley
Journal:  BMJ       Date:  2002-04-06

4.  Communicating risk reductions. Data were selectively used.

Authors:  J McMurray
Journal:  BMJ       Date:  1999-02-27

5.  Thresholds for normal blood pressure and serum cholesterol.

Authors:  Steinar Westin; Iona Heath
Journal:  BMJ       Date:  2005-06-25

6.  [Ethical problems in prescribing drugs of not very significant clinical effectiveness].

Authors:  Santiago Alvarez Montero
Journal:  Aten Primaria       Date:  2006-09-30       Impact factor: 1.137

7.  Risky communication: pitfalls in counseling about risk, and how to avoid them.

Authors:  K O'Doherty; G K Suthers
Journal:  J Genet Couns       Date:  2007-05-01       Impact factor: 2.537

8.  A simple computer program for guiding management of cardiovascular risk factors and prescribing.

Authors:  A D Hingorani; P Vallance
Journal:  BMJ       Date:  1999-01-09

9.  Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes.

Authors:  David K Lewis; Jude Robinson; Ewan Wilkinson
Journal:  BMJ       Date:  2003-10-11

10.  The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial.

Authors:  Cheryl L L Carling; Doris Tove Kristoffersen; Victor M Montori; Jeph Herrin; Holger J Schünemann; Shaun Treweek; Elie A Akl; Andrew D Oxman
Journal:  PLoS Med       Date:  2009-08-25       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.